<DOC>
	<DOCNO>NCT02073071</DOCNO>
	<brief_summary>This two stage open-label , single-arm , multicenter observational study .</brief_summary>
	<brief_title>Effects Infant Formula Growth Tolerance Preterm/Low Birth Weight Infants</brief_title>
	<detailed_description>Stage 1 : In hospital , preterm/low birth weight infant less equal 34 week gestational age birth , birth weight ≥ 1000g &lt; 1800g condition meet enrollment criterion feed formula without parenteral nutrition discharge . Stage 2 : Post-discharge , infant birth weight &lt; =1500g follow formula per standard care accept standard care include feed infant 's weight &gt; or= 25th percentile growth expectation base correct age ( P25 ) infant reach 9 month correct age .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<criteria>Inclusion Criteria Stage 1 : Less equal 34 week gestational age birth , birth weight ≥ 1000g &lt; 1800g ; Apgar score 5 minute birth ≥ 7 ; Infant 21 day less age enrollment ; Only singleton twin birth ; Infants receive early enteral feeding stably ( reach 50 % high require daily total calorie ) whose parents/guardians investigator select Similac Special Care ( SSC ) feeding ; Infant classify appropriate gestational age ( AGA ) classify asymmetric small gestational age ( SGA ) ( Asymmetric SGA : Weight 10th percentile , head circumference great equal 10th percentile ) enrollment preapproved sponsor ; Inclusion Criteria Stage 2 : Infants birth weight &lt; = 1500g , subject whose parents/guardians investigator select NeoSure continue feed hospital discharge . Exclusion Criteria Stage 1 : Serious congenital chromosomal metabolic abnormality may affect growth development ; Congenital gastrointestinal malformation , include limited congenital megacolon gastricintestinal perforation ; Serious complication associate preterm birth , include limited necrotizing enterocolitis ( NEC ) , septicemia sepsis ; Other serious disorder cardiac/respiratory/endocrine/hematological/ gastrointestinal/other system , serious disease require surgical intervention ; Maternal incapacity : include maternal drug , cocaine alcohol abuse pregnancy current ; Infants receive experimental treatment , participate clinical trial receive study intervention unrelated study within 30 day prior enrollment ; Infants receive planned receive breastfeeding infant formula ( powder ) SSC calorie intake ≥25 % require daily total calorie Intubation ventilation time enrollment . Exclusion Criteria Stage 2 : Infants receive breastfeed infant formula ( powder ) hospitalization SSC calorie intake ≥25 % require daily total calorie Infants plan receive breastfeeding infant formula ( powder ) NeoSure discharge calorie intake ≥25 % require daily total calorie</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Days</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>